Implantable cardioverter-defibrillator therapy in patients with Brugada syndrome is effective for prevention of fatal arrhythmias.

A scientific statement regarding risk-based primary prevention of heart failure has been published by the American Heart Association.

For patients with myocardial infarction (MI), early oral combination lipid-lowering therapy (LLT) is beneficial.

An intensive BP reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and older with untreated hypertension.

Metabolic syndrome (MetS) and its individual components are associated with an increased risk for young-onset dementia (YOD).

The FDA has extended the review period for the NDA for aficamten for the treatment of patients with obstructive hypertrophic cardiomyopathy.

The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. Drug ...

A study was conducted to examine gender and sociodemographic disparities in ICD access for patients with high-risk heart failure.

In patients with nickel hypersensitivity, there is increased risk for device syndrome within the first 90 days following patent foramen ovale closure.

A scientific statement has been published by the American Heart Association regarding the effect of sleep health on cardiometabolic health.

Average and brisk walking pace are associated with a decreased risk for all cardiac arrhythmias, atrial fibrillation, and other arrhythmias.

Exposure to antihypertensives, NSAIDs, and statins showed a strong correlation with older Parkinson disease age at onset, while smoking and family history, however, correlated with younger age at ...